BLLN

BillionToOne, Inc.

64
Fundamentals65/ 100
Valuation50/ 100
Upside potential63/ 100
Risk potential39/ 100

BLLN lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.

BLLN Fundamentals

MetricStatus
Healthy
Stable
Healthy
Strong

BLLN's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.

BLLN PE Valuation

BLLN has no meaningful PE right now: it lost money over the past year.

BLLN Forward outlook

MetricOutlook
--
Strong growth
Strong growth
Strongly improving
Limited
Low

Analysts expect strong earnings and revenue growth for BLLN, with profitability improving. However, they disagree widely on these estimates.

BLLN Risk to reward

ScenarioChangePrice
Upside+66%$184.02
Downside-39%$67.70

Calculated from the latest close: $110.79 on Nov 12.

BLLN's one-year upside scenario is somewhat larger than its downside: +66% against −39%.

BLLN Earnings Per Share

Q4 2024: $-0.93Q1 2025: $-0.75Q2 2025: $-0.68Q3 2025: $-0.25Forward: $0.79
Q4 2024: $-0.93Q1 2025: $-0.75Q2 2025: $-0.68Q3 2025: $-0.25Forward: $0.79

BLLN Quarterly Revenue

Q1 2024: $33MQ2 2024: $36MQ3 2024: $38MQ4 2024: $45MQ1 2025: $59MQ2 2025: $67MQ3 2025: $84MQ4 2025: $96MQ1 2026: $108MQ2 2026: $109MQ3 2026: $123M
Q1 2024: $33MQ2 2024: $36MQ3 2024: $38MQ4 2024: $45MQ1 2025: $59MQ2 2025: $67MQ3 2025: $84MQ4 2025: $96MQ1 2026: $108MQ2 2026: $109MQ3 2026: $123M
QuarterRevenueYoY
Q3 2026$123M+47%
Q2 2026$109.4M+64%
Q1 2026$108.4M+84%
Q4 2025$96.1M+113%
Q3 2025$83.5M+117%
Q2 2025$66.6M+84%
Q1 2025$59M+79%

BLLN's revenue has grown year over year every quarter since early 2025: $123M last quarter, up 47% from the same quarter a year ago.

BLLN Free Cash Flow

Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: −$11MQ1 2025: $278,000Q2 2025: $0Q3 2025: --Q4 2025: $9MQ1 2026: $11MQ2 2026: $5MQ3 2026: $9M
Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: −$11MQ1 2025: $278,000Q2 2025: $0Q3 2025: --Q4 2025: $9MQ1 2026: $11MQ2 2026: $5MQ3 2026: $9M
QuarterFree cash flowYoY
Q2 2026$5.1M+$5.1M
Q1 2026$11M+3842%
Q4 2025$9.3M+$19.8M

BLLN Total Shares

Q1 2024: 45MQ2 2024: 45MQ3 2024: 45MQ4 2024: 45MQ1 2025: 45MQ2 2025: 45MQ3 2025: 16MQ1 2026: 53MQ2 2026: 54MQ3 2026: 54M
Q1 2024: 45MQ2 2024: 45MQ3 2024: 45MQ4 2024: 45MQ1 2025: 45MQ2 2025: 45MQ3 2025: 16MQ1 2026: 53MQ2 2026: 54MQ3 2026: 54M
PeriodChange %Net change
Quarterly-1.3%-723K shares
1 year+20%+9M shares

BLLN has 54M diluted shares, up 20% from a year ago.

BLLN Net Leverage

Q3 2026: -9.1x
Q3 2026: -9.1x
QuarterNet LeverageStatus
Q3 2026-9.1xNet Cash

BLLN has more cash than debt.

BLLN Weekly Momentum

MetricValueStatus
RSI52.0Neutral
Stochastic46.5Neutral

BLLN's weekly RSI is 52 (neutral) and its Stochastic is 47 (neutral).

BLLN PE vs Healthcare Sector

BLLN has no meaningful PE right now: it lost money over the past year.

BLLN Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$108.91.8% above
20 week MA$109.61.1% above
50 week MA$96.914% above

BLLN is in an uptrend: it's above all three of its weekly moving averages, and 14% above its 50-week average.

BLLN Yearly ROI

YearStart priceEnd priceROI
2025$100.0$89.3-11%
2026 YTD$89.3$110.8+24%

BLLN has finished every year since 2025 lower, and it's up 24% so far in 2026.

Give your agent the market.

Get API key